leisure time -WSS

leisure time

author：fashion 2025-09-27 13:10:10 - browse：19

Person wearing a smart watch. -- first opinion coverage from STAT — Adobe

The Apple Watch has secured a new qualification from the Food and Drug Administration that could make the smartwatch an appealing tool for medical device companies hoping to illustrate the benefits of a common heart procedure.

Last week, the Apple Watch’s Atrial Fibrillation History feature became the first digital tool qualified under the Medical Device Development Tools (MDDT) program. Released in 2022, the feature estimates a user’s A-fib burden, or how much time they spend in atrial fibrillation, which is an irregular heart rhythm that can cause shortness of breath and fatigue, and is also linked to an increased risk of stroke.

The qualification means that FDA has determined in advance that sponsors can use the feature as a secondary endpoint in clinical trials without having to do additional work. Specifically, the Apple Watch is qualified for use as a secondary endpoint in clinical trials for cardiac ablation devices, which reduce the electrical signals that cause A-fib by scarring the heart with extreme heat or cold energy. Pulsed field ablation is the latest version of the technology, using a controlled electric field to scar tissue rather than the riskier thermal energy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Readers discuss the intersection of pregnancy and addiction

explore

WSS

Key Senate panel to consider PBM, drug pricing reform package

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Live blog: Hearing on CRISPR

Curing rare childhood diseases will falter unless Congress steps up

'Essentially witchcraft:' A former naturopath takes on the field

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

Wikipedia

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Wikipedia

Jerome Adams on the need for new antivirals for Covid

Coercive sterilizations revealed by STAT prompt outrage

Affirmative action in medical school literally saved lives

Teladoc has a new CEO, but challenges remain the same

How to save PrEP access — and even expand it

Curing rare childhood diseases will falter unless Congress steps up

Novavax promises a turnaround & Lilly roils the obesity market

How neuroscience research could help beat back brain cancer

BioMarin wins approval for gene therapy to treat hemophilia A

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

explore

Lung cancer screening guidelines updated for cigarette smokers

Coloradans with cystic fibrosis could lose access to Trikafta

Inari Medical to buy amputation prevention company LimFlow

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Humans aren't the only ones with an imagination. Rats have it too

Live blog: Hearing on CRISPR

hotspot

entertainment

explore

knowledge